Table 1 The results of baseline laboratory and clinical investigations of the studied groups

Age (years, mean ± SD)

50.27 ± 6.05

50.9 ± 7.23

Sex

Male

17 (85%)

16 (80%)

Female

3 (15%)

4 (20%)

Residence

Urban

7 (35%)

8 (40%)

Rural

13 (65%)

12 (60%)

Clinical features

Hemoglobin (g/dl)

12.22 ± 2.24

9.77 ± 2.13

TLC (1,000/cmm)

5.81 ± 3.22

5.73 ± 2.24

Platelets (1,000/cmm)

105.95 ± 47.17

91.75 ± 33.67

Total bilirubin (N, 0.1 to 1 mg/dl)

1.88 ± 1.05

2.51 ± 0.94

Serum albumin (N, 3.4 to 5.2 g/dl)

2.59 ± 0.28

2.62 ± 0.37

PC

55.34% ± 9.06%

52.85 ± 10.16%

INR (N, 1)

1.53 ± 0.19

1.66 ± 0.33

ALT folds

1.35 ± 0.87

0.9 ± 0.52

AST folds

2.29 ± 1.51

1.81 ± 0.84

Serum creatinine (0.7-1.2 mg/dl)

1.1 ± 0.29

1.06 ± 033

Encephalopathy

1 (5%)

2 (10%)

Ascites and lower-limb edema

15 (75%)

15 (75%)

Bleeding tendency

10 (50%)

10 (50%)

Hematemesis

0 (0)

2 (10%)

Spleen size

Average size

5 (25%)

5 (25%)

Mild splenomegaly

11 (55%)

12 (60%)

Moderate splenomegaly

4 (20%)

3 (15%)

Splenectomy

0

0

Ascites

Absent

9 (45%)

5 (25%)

Mild

2 (10%)

2 (10%)

Moderate

7 (35%)

9 (45%)

Massive

2 (10%)

4 (20%)